Literature DB >> 24960476

Evaluation of quality of life in fertile Turkish women with severe endometriosis.

S Kiykac Altinbas1, Y Bayoglu Tekin, B Dilbaz, S Dilbaz.   

Abstract

We assessed the impact of pain, dysmenorrhoea and dyspareunia on the quality of life among Turkish fertile women with severe endometriosis. A total of 33 patients with histopathologically diagnosed severe endometriosis (Stage IV, revised criteria of the American Fertility Society (rAFS score) were enrolled into the study. Patients reported chronic pelvic pain using a visual analogue scale (VAS) and severity of dysmenorrhoea, dyspareunia and pelvic tenderness using the verbal rating scale (VRS). Quality of life (physical, psychological, social, environmental domains) was evaluated using the World Health Organization Quality of Life Assessment-BREF (WHOQOL-BREF). There were no correlations between quality of life and VRS and VAS scores of chronic pelvic pain in patients with dyspareunia (p > 0.05). VRS in patients with dysmenorrhoea negatively correlated with physical, social and environmental dimensions of quality of life (r = -0.382, r = -0.221, r = -0.373 and p = 0.028, p = 0.013, p = 0.033, respectively). Although the severity of dysmenorrhoea seems to be related with lower quality of life, chronic pelvic pain and dyspareunia due to endometriosis may not have any deleterious effects on the quality of life.

Entities:  

Keywords:  Endometriosis; dysmenorrhoea; dyspareunia; pelvic pain; quality of life

Mesh:

Year:  2014        PMID: 24960476     DOI: 10.3109/01443615.2014.930110

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  7 in total

1.  Analysis of preoperative and postoperative quality of life, sexual function, and sleep in patients with endometriosis: a prospective cohort study.

Authors:  Belfin Nur Arici Halici; Fatih Aktoz; Meric Kabakci; Gurkan Kiran; Pinar Ozcan
Journal:  Arch Gynecol Obstet       Date:  2022-04-22       Impact factor: 2.344

2.  Systematic review of quality of life measures in patients with endometriosis.

Authors:  Nicolas Bourdel; Pauline Chauvet; Valentina Billone; Giannis Douridas; Arnaud Fauconnier; Laurent Gerbaud; Michel Canis
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

Review 3.  Impact of Endometriosis on Life-Course Potential: A Narrative Review.

Authors:  Stacey A Missmer; Frank F Tu; Sanjay K Agarwal; Charles Chapron; Ahmed M Soliman; Stephanie Chiuve; Samantha Eichner; Idhaliz Flores-Caldera; Andrew W Horne; Alexandra B Kimball; Marc R Laufer; Nicholas Leyland; Sukhbir S Singh; Hugh S Taylor; Sawsan As-Sanie
Journal:  Int J Gen Med       Date:  2021-01-07

Review 4.  The Role of Visceral Therapy in the Sexual Health of Women with Endometriosis during the COVID-19 Pandemic: A Literature Review.

Authors:  Tomasz Gozdziewicz; Grazyna Jarzabek-Bielecka; Dawid Luwanski; Malgorzata Wojcik; Katarzyna Plagens-Rotman; Malgorzata Mizgier; Magdalena Pisarska-Krawczyk; Witold Kedzia
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

5.  A prospective, single-centre, single-arm, open label study of the long term use of a gonadotropin releasing hormone agonist (Triptorelin SR, 11.25 mg) in combination with Tibolone add-back therapy in the management of chronic cyclical pelvic pain.

Authors:  Sallwa M Alshehre; Sheila Duffy; Georgina Jones; William L Ledger; Mostafa Metwally
Journal:  Reprod Biol Endocrinol       Date:  2020-04-14       Impact factor: 5.211

6.  Health-related quality of life (Nottingham Health Profile) in patients with endometriomas: correlation with clinical variables and self-reported limitations.

Authors:  Karolina Chmaj-Wierzchowska; Paweł Rzymski; Małgorzata Wojciechowska; Ilona Parda; Maciej Wilczak
Journal:  Arch Med Sci       Date:  2019-02-05       Impact factor: 3.318

7.  Exploring the impact of endometriosis on women's lives: A qualitative study in Iran.

Authors:  Masoumeh Namazi; Zahra Behboodi Moghadam; Armin Zareiyan; Mina Jafarabadi
Journal:  Nurs Open       Date:  2020-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.